Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Total Cordyceps Militaris is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanxi Buchang Pharmaceutical. It is derived from the fungus *Cordyceps militaris*, which is cultivated as a substitute for the rarer *Cordyceps sinensis*. The product is standardized to contain bioactive compounds such as cordycepin (3'-deoxyadenosine), adenosine, and various polysaccharides. These constituents are associated with immunomodulatory, anti-inflammatory, and antioxidant activities. Total Cordyceps Militaris is approved in China for general health maintenance, often used to support immune function, reduce fatigue, and improve overall vitality.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on total cordyceps militaris.